Top Markets
#1 Gama Token Gama Token +9.13%
#2 Audiera Audiera +4.59%
#3 Cross Cross +4.58%
#4 Ribbita by Virtuals Ribbita by Virtuals +3.14%
#5 OKZOO OKZOO +2.26%
#6 Humanity Humanity +2.23%
#7 Quack AI Quack AI +2.19%
#8 Akedo Akedo +2.08%
#9 Fabric Protocol Fabric Protocol +1.82%
#10 Kinesis Gold Kinesis Gold +1.82%
Coin of the day
Gama Token Gama Token
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

EIGR
Kedudukan dalam Saham #36561
Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company... Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and bringing to market targeted therapies for rare and ultra-rare diseases across the United States and internationally. Its primary investigational drug, Lonafarnib, an orally administered small molecule, is currently undergoing Phase III clinical trials for the treatment of hepatitis delta virus (HDV) infection. Other promising candidates in its portfolio include Lambda, which has completed Phase II clinical trials and is designed to target type III interferon receptors; Lonafarnib, also being evaluated for progeria and progeroid laminopathies; and Avexitide, an agent for congenital hyperinsulinism that has also successfully concluded Phase II studies for post-bariatric hypoglycemia. Established in 2008, Eiger BioPharmaceuticals, Inc. maintains its headquarters in Palo Alto, California.
Harga Saham
$1.73
Disegerakkan terakhir: 2025-06-17
Modal Pasaran
$2.55M
Perubahan (1 hari)
-0.29%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Eiger BioPharmaceuticals, Inc. (EIGR)

Kategori

Healthcare
Sejarah hasil dividen untuk Eiger BioPharmaceuticals, Inc. (EIGR)
Hasil dividen (TTM) bagi Eiger BioPharmaceuticals, Inc. (simbol saham: EIGR) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Eiger BioPharmaceuticals, Inc. (EIGR) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
Syarikat Hasil Dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.48%
BE